C M Bate

913 citations

18 papers · 727 indexed · h-index 13

Impact in

Gastroenterology top 0.5%
- Gastroesophageal reflux and treatments
- Gastrointestinal motility and disorders
Surgery top 5%
- Helicobacter pylori-related gastroenterology studies
- Eosinophilic Esophagitis
- Esophageal and GI Pathology
- Esophageal Cancer Research and Treatment

Papers in

Gastroenterology 14
- Gastroesophageal reflux and treatments 12
- Gastrointestinal motility and disorders 3
Surgery 13
- Eosinophilic Esophagitis 9
- Helicobacter pylori-related gastroenterology studies 7
- Esophageal and GI Pathology 4

Co-authors: Michael D. Taylor P. D. I. RICHARDSON R A Mountford Simon F. Crowe M W Dronfield G Tildesley Anthony Axon S P Wilkinson
Journals: Alimentary Pharmacology & Therapeutics (6 papers)Gut (3 papers)PharmacoEconomics (2 papers)Journal of Medical Economics (1 paper)The Lancet (1 paper)
Partner nations: United Kingdom Ireland Australia

In The Last Decade

C M Bate

18 papers receiving 685 citations

Peers

Countries citing papers authored by C M Bate

Since Specialization

Citations

This map shows the geographic impact of C M Bate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C M Bate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C M Bate more than expected).

Fields of papers citing papers by C M Bate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C M Bate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C M Bate. The network helps show where C M Bate may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C M Bate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C M Bate Line = papers co-authored together C M Bate links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	The management of acid-related disorders: the burden of disease and the need for effective treatment Journal of Medical Economics ·C M Bate	1998	1
2	Omeprazole is more effective than cimetidine for the relief of all grades of gastro‐oesophageal reflux disease‐associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis Alimentary Pharmacology & Therapeutics ·C M Bate, Gregory Slabaugh, Anthony Axon, Frank E. Murray, G Tildesley, たつおしばさき, Michael D. Taylor	1997	74
3	Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis Alimentary Pharmacology & Therapeutics ·C M Bate, S M Griffin, P. W. N. Keeling, A. T. R. Axon, M W Dronfield, R Chapman, D. O’Donoghue, J Calam, Simon F. Crowe, R A Mountford, Monette O. Koh, Michael D. Taylor, P. D. I. RICHARDSON	1996	112
4	Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole Alimentary Pharmacology & Therapeutics ·G. D. Bell, C M Bate, A. T. R. Axon, G Tildesley, Jackie L. Martin, Michael D. Taylor, P. D. I. RICHARDSON	1996	15
5	Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double‐blind, randomized trial Alimentary Pharmacology & Therapeutics ·G. D. Bell, C M Bate, Anthony Axon, G Tildesley, G. D. Kerr, Gregory Slabaugh, たつおしばさき, Michael D. Taylor	1995	45
6	Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group. Gut ·C M Bate, S. N. Booth, Simon F. Crowe, R A Mountford, P. W. N. Keeling, Emily Wilson, Michael D. Taylor, P. D. I. RICHARDSON	1995	75
7	A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture Gastroenterology ·Paul Smith, G. D. Kerr, R Cockel, Barry Ross, C M Bate, Paul E. Brown, M W Dronfield, Jong-Il Park, W.S. Hislop, A Theodossi, Aurélia Horpin, Petra Fiedlerová, Michael D. Taylor, P. D. Richardson	1994	140
8	Omeprazole vs Ranitidine and Cimetidine in Reflux Oesophagitis PharmacoEconomics ·C M Bate	1994	4
9	Clinical and Economic Factors in the Selection of Drugs for Gastroesophageal Reflux Disease PharmacoEconomics ·C M Bate, Paul Richardson	1993	13
10	Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis? Alimentary Pharmacology & Therapeutics ·C M Bate, S. N. Booth, Simon F. Crowe, Emily Wilson, Michael D. Taylor, P. D. I. RICHARDSON	1993	32
11	Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. Gut ·C M Bate, P. W. N. Keeling, C O'Morain, S P Wilkinson, Dona Foster, R A Mountford, Monica Naomi, R.F. Harvey, Wladyslaw Romanowski, Melinda B. Davis	1990	106
12	Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut ·C M Bate, S P Wilkinson, G V Bradby, Melissa Bateson, W.S. Hislop, Simon F. Crowe, C P Willoughby, Elizabeth Peers, P. D. I. RICHARDSON	1989	25
13	Symptom relief and duodenal ulcer healing with omeprazole or cimetidine Alimentary Pharmacology & Therapeutics ·Simon F. Crowe, S P Wilkinson, C M Bate, C P Willoughby, Elizabeth Peers, P. D. I. RICHARDSON, (unknown)	1989	16
14	Omeprazole Provides Faster Ulcer Healing and Symptom Relief than Cimetidine in the Treatment of Gastric Ulcer Scandinavian Journal of Gastroenterology ·C M Bate, G V Bradby, S P Wilkinson, Ahmad fahrudin Ansari, W.S. Hislop, Simon F. Crowe, C P Willoughby, Elizabeth Peers, P. D. I. RICHARDSON	1989	4
15	Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy Cancer Chemotherapy and Pharmacology ·D. Parker, C M Bate, A. W. Craft, John Graham‐Pole, J. S. Malpas, A G Stansfeld	1980	32
16	Some surgical aspects of homozygous beta-thalassaemia British journal of surgery ·Esperanza Bou Barragán, C M Bate, G. Humphries	1977	7
17	ALPHA-BETA THALASSÆMIA The Lancet ·C M Bate, G. Humphries	1977	22
18	Thalassaemia in Cyprus Proceedings of the Royal Society of Medicine ·C M Bate	1975	4

About C M Bate

C M Bate is a scholar working on Gastroenterology, Surgery, Classics, Pulmonary and Respiratory Medicine and Dermatology, having authored 18 papers that have together received 727 indexed citations. Recurring topics across this work include Gastroesophageal reflux and treatments (12 papers), Eosinophilic Esophagitis (9 papers), Helicobacter pylori-related gastroenterology studies (7 papers), Esophageal and GI Pathology (4 papers), Gastrointestinal motility and disorders (3 papers), Potassium and Related Disorders (3 papers), Lanthanide and Transition Metal Complexes (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Gastroenterology (583 citations), Surgery (627 citations), Speech and Hearing (29 citations), Genetics (33 citations) and Pulmonary and Respiratory Medicine (94 citations). C M Bate has collaborated with scholars based in United Kingdom, Ireland and Australia. Frequent co-authors include Michael D. Taylor, P. D. I. RICHARDSON, R A Mountford, Simon F. Crowe, M W Dronfield, G Tildesley, Anthony Axon, S P Wilkinson, G. D. Kerr and S. N. Booth. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Gut, PharmacoEconomics, Journal of Medical Economics and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact